Save over 95% with generic version of Lenvima and 90% with brand from Eisai (English packaging)
Click here for information on Sun Pharma generics (Immediate availability)
Click here for information on Shilpa Medicare generics (Immediate availability)
Information about Lenvima (Lenvatinib)
Lenvima is an oral medication that contains lenvatinib, a targeted therapy that inhibits multiple receptor tyrosine kinases. It is primarily used in the treatment of various types of cancer, including thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma.
Product Highlights
- Treatment of differentiated thyroid cancer (DTC) in adults.
- First-line treatment of unresectable hepatocellular carcinoma (HCC) in adults.
- Combination therapy for advanced renal cell carcinoma (RCC) in adults.
Key Ingredient
Key Benefits
- Proven effectiveness in shrinking tumors and improving progression-free survival.
- Oral route allows for convenient home management.
- Applicable for several cancer types, enhancing treatment options.
Direction of Use
- Typically prescribed at a starting dose of 24 mg once daily for most indications; adjustments may be made based on tolerance and side effects.
- Take with or without food; maintain consistent timing daily.
Safety Concerns
- Common side effects may involve hypertension, fatigue, diarrhea, reduced appetite, and nausea.
- Potential risks include liver toxicity, heart problems, and severe bleeding.
Avoid Lenvima (Lenvatinib) If
- You have a known allergy to lenvatinib or any of its components.
- You are pregnant, planning to become pregnant, or breastfeeding without medical consultation.
- You have uncontrolled hypertension or certain other serious medical conditions without proper evaluation.
